Michael J. Sorich - Publications, H-index & Citations

Michael J. Sorich

Flinders University

44H指数

270论文数

8.1K被引数

收录论文 117

发表时间

Sex-based prognosis in industry-sponsored advanced solid tumor trials: an individual participant data meta-analysis of survival and adverse events 基于性别的预后在行业赞助的晚期实体瘤试验中：一项关于生存期和不良事件的个体参与者数据荟萃分析

JNCI-Journal of the National Cancer Institute

IF7.2

2026-04-01

PREAI

Chhetri, Rakchha; Modi, Natansh D.; Menz, Bradley D.; Cornelisse, Erik; Postma, David; Kuderer, Nicole M.; Lyman, Gary H.; Swain, Sandra M.; Li, Lee X.; Abuhelwa, Ahmad Y.; McKinnon, Ross A.; Vatandoust, Sina; Kichenadasse, Ganessan; Rowland, Andrew; Sorich, Michael J.; Hopkins, Ashley M.

Heterogeneous treatment effect of immune checkpoint inhibitors by pretreatment prognosis in randomized controlled trials 随机对照试验中基于预治疗预后的免疫检查点抑制剂异质性治疗效果

JNCI Cancer Spectrum

IF4.1

2026-04-01

PREAI

Li, Lee X.; Shahnam, Adel; Kichenadasse, Ganessan; Murray, Lewis; Woodman, Richard; Abuhelwa, Ahmad Y.; Modi, Natansh D.; Rowland, Andrew; Hopkins, Ashley M.; Sorich, Michael J.

Progressive Lesion Type is Predictive of Post-progression Survival in First-line Chemoimmunotherapy for Non-small Cell Lung Cancer.进展性病变类型是预测非小细胞肺癌一线化疗免疫疗法后进展生存期的指标。

Cancer Letters

IF10.1

2025-12-10

PREAI

Yuan Gao; Lee X. Li; Andrew Rowland; Christos S. Karapetis; Natalie Parent; Ganessan Kichenadasse; Ashley M. Hopkins; Michael J. Sorich

Integrating the Caring Life Course Theory and Artificial Intelligence Applications to Enhance Cancer Care Across the Continuum 整合关怀生命历程理论与人工智能应用，以提升癌症全程护理

SEMINARS IN ONCOLOGY NURSING

IF2.3

2025-12-01

OAAI

Christina, Juliana; Ford, Kelly; Menz, Bradly; Sorich, Michael; Hopkins, Ashley; Ramsey, Imogen; Duddle, Maree; Kitson, Alison; Paterson, Catherine

Discrimination, calibration, and variable importance in statistical and machine learning models for predicting overall survival in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors 歧视性、校准和变量重要性在用于预测接受免疫检查点抑制剂治疗的晚期非小细胞肺癌患者总生存期的统计和机器学习模型中

Journal of Clinical Epidemiology

IF5.2

2025-11-21

OAAI

Lee X. Li; Ashley M. Hopkins; Richard Woodman; Ahmad Y. Abuhelwa; Yuan Gao; Natalie Parent; Andrew Rowland; Michael J. Sorich

Automating cancer registries: Pearls and pitfalls 自动化癌症登记：经验与教训

Health Information Management Journal

IF1.8

2025-11-04

PREAI

Shrirajh Satheakeerthy; Mark Beecher; Andrew EC Booth; Brandon Stretton; Joshua Kovoor; Aashray Gupta; Shaun Evans; Sarah Howson; Jesikah Logan; Carolyn Qian; Yu-Hsiang Lin; Christina Gao; Weng Onn Chan; Michael J Sorich; Michael P Brown; Rosalind L Jeffree; Stephen Bacchi

Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer 常用合并用药与乳腺癌患者生存及不良事件结局的关联

Cancer Medicine

IF3.1

2025-10-29

OAAI

Natansh D. Modi; Ahmad Y. Abuhelwa; Nicole M. Kuderer; Lee X. Li; Gary H. Lyman; Bogda Koczwara; Ganessan Kichenadasse; Luke A. Selth; Ceara Rickard; Mark Haseloff; Agnes Vitry; Richard Woodman; Jessica M. Logan; Huah Shin Ng; Michael D. Wiese; Ross A. McKinnon; Andrew Rowland; Michael J. Sorich; Ashley M. Hopkins

Generative AI's healthcare professional role creep: a cross-sectional evaluation of publicly accessible, customised health-related GPTs 生成式AI在医疗专业人员角色中的蔓延：对公开可访问、定制化健康相关GPT的横断面评估

FRONTIERS IN PUBLIC HEALTH

IF3.4

2025-05-09

OAAI

Chu, Bianca; Modi, Natansh D.; Menz, Bradley D.; Bacchi, Stephen; Kichenadasse, Ganessan; Paterson, Catherine; Kovoor, Joshua G.; Ramsey, Imogen; Logan, Jessica M.; Wiese, Michael D.; McKinnon, Ross A.; Rowland, Andrew; Sorich, Michael J.

Statin use and survival in CLL/SLL treated with ibrutinib: pooled analysis of 4 randomized controlled trials 他汀类药物使用与接受伊布替尼治疗的CLL/SLL患者的生存：4项随机对照试验的合并分析

Blood Advances

IF7.1

2025-04-25

OAAI

Ahmad Y. Abuhelwa; Sara A. Almansour; Jennifer R. Brown; Humaid O. Al-Shamsi; Ziad Abuhelwa; Zelal Kharaba; Yasser Bustanji; Mohammad H. Semreen; Salma Ali; Ahmad Alhuraiji; Ross A. McKinnon; Michael J. Sorich; Karem H. Alzoubi; Ashley M. Hopkins

Evaluation of hyperprogressive disease with atezolizumab plus bevacizumab for hepatocellular carcinoma: A secondary analysis of the IMbrave150 trial 阿特珠单抗联合贝伐单抗治疗肝细胞癌的超进展性疾病评估: IMbrave150试验的二次分析

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2025-03-01

OAAI

Gao, Yuan; Cheng, Ann-Lii; Li, Lee X.; Parent, Natalie; Kichenadasse, Ganessan; Karapetis, Christos S.; Rowland, Andrew; Hopkins, Ashley M.; Sorich, Michael J.

Phenotyping to predict 12-month health outcomes of older general medicine patients

AGING CLINICAL AND EXPERIMENTAL RESEARCH

IF3.4

2025-02-22

OAAI

Woodman, Richard John; Bryant, Kimberly; Sorich, Michael J.; Thompson, Campbell H.; Russell, Patrick; Pilotto, Alberto; Mangoni, Aleksander A.

Tumour Mutational Burden and Immune Checkpoint Inhibitor Response in Non-small Cell Lung Cancer: A Continuous Modelling Approach

TARGETED ONCOLOGY

IF4

2025-01-07

OAAI

Sorich, Michael J.; Manning-Bennett, Arkady T.; Li, Lee X.; Shahnam, Adel; Kichenadasse, Ganessan; Karapetis, Christos S.; Abuhelwa, Ahmad Y.; Mckinnon, Ross A.; Rowland, Andrew; Hopkins, Ashley M.

The Triage and Diagnostic Accuracy of Frontier Large Language Models: Updated Comparison to Physician Performance 前沿大语言模型的分类和诊断准确性: 与医生表现的更新比较

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2024-12-06

OAAI

Sorich, Michael Joseph; Mangoni, Arduino Aleksander; Bacchi, Stephen; Menz, Bradley Douglas; Hopkins, Ashley Mark

Gender Representation of Health Care Professionals in Large Language Model-Generated Stories

JAMA NETWORK OPEN

IF9.7

2024-09-23

OAAI

Menz, Bradley D.; Kuderer, Nicole M.; Chin-Yee, Benjamin; Logan, Jessica M.; Rowland, Andrew; Sorich, Michael J.; Hopkins, Ashley M.

Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-09-02

OAAI

Almansour, Sara A.; Alqudah, Mohammad A. Y.; Abuhelwa, Ziad; Al-Shamsi, Humaid O.; Alhuraiji, Ahmad; Semreen, Mohammad H.; Bustanji, Yasser; Alzoubi, Karem H.; Modi, Natansh D.; Mckinnon, Ross A.; Sorich, Michael J.; Hopkins, Ashley M.; Abuhelwa, Ahmad Y.

Establishing the capacity to monitor proteins relevant to the study of drug exposure and response using liver-derived extracellular vesicles

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2024-07-30

OAAI

Newman, Lauren A.; Useckaite, Zivile; Wu, Ting; Sorich, Michael J.; Rowland, Andrew

A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials

BMC CANCER

IF3.4

2024-03-25

OAAI

Li, Lee X.; Socinski, Mark A.; Kichenadasse, Ganessan; Karapetis, Christos S.; Shahnam, Adel; Mckinnon, Ross A.; Rowland, Andrew; Hopkins, Ashley M.; Sorich, Michael J.

Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis 针对健康信息生成的大型语言模型的当前保障措施，风险缓解和透明度措施: 重复的横截面分析

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2024-03-20

OAAI

Menz, Bradley; Kuderer, Nicole; Bacchi, Stephen; Modi, Natansh; Chin-Yee, Benjamin; Hu, Tiancheng; Rickard, Ceara; Haseloff, Mark; Vitry, Agnes; Mckinnon, Ross; Kichenadasse, Ganessan; Rowland, Andrew; Sorich, Michael; Hopkins, Ashley

Quality and safety of artificial intelligence generated health information

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2024-03-20

PREAI

Sorich, Michael J.; Menz, Bradley; Hopkins, Ashley

Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation 支持药物批准的临床研究报告的可及性: 横断面评估

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2024-03-01

OAAI

Hopkins, Ashley M.; Modi, Natansh D.; Rockhold, Frank W.; Hoffmann, Tammy; Menz, Bradley D.; Veroniki, Areti-Angeliki; Mckinnon, Ross A.; Rowland, Andrew; Swain, Sandra M.; Ross, Joseph S.; Sorich, Michael J.

研究方向